Cagrilintide is a long-acting synthetic analogue of amylin, a hormone naturally co-secreted with insulin that helps regulate appetite and glucose metabolism. In laboratory and clinical research, Cagrilintide is studied for its potential effects on body weight management and metabolic regulation, both on its own and in combination with GLP-1 receptor agonists such as semaglutide (the combination is sometimes called CagriSema). Preclinical and early clinical studies suggest it may influence appetite signaling, energy balance, and glucose handling in experimental models.

For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.